Western blotting analysis also demonstrated that NGI-1 substantially reduced the phosphorylation levels of EGFR, AKT (Ser473 and Thr308) and ERK5 in HCC cells, regardless of whether these cells were treated with EGF (Fig. 6j). This evidence concerns the gene EGF and hepatocellular carcinoma.